flecainide has been researched along with tetradecanoylphorbol acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobuchi, H; Nojima, S; Saibara, T; Utsumi, K; Yasuda, T | 1 |
| Walsh, KB; Zhang, J | 1 |
2 other study(ies) available for flecainide and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Selective inhibition of human TNF-alpha action by flecainide acetate, an antiarrhythmic drug.
Topics: Animals; Anti-Arrhythmia Agents; Cell Survival; Dose-Response Relationship, Drug; Flecainide; Humans; In Vitro Techniques; L Cells; Membrane Potentials; Mice; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphoproteins; Phosphotyrosine; Superoxides; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1995 |
Neonatal rat cardiac fibroblasts express three types of voltage-gated K+ channels: regulation of a transient outward current by protein kinase C.
Topics: 4-Aminopyridine; Angiotensin II; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Blotting, Western; Calcium; Calcium Signaling; Electrophysiology; Fibroblasts; Flecainide; Heart; Myocardium; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Protein Kinase C; Rats; Signal Transduction; Tetradecanoylphorbol Acetate | 2008 |